ex Vivo Study of the Inflammatory Response Associated With Hidradenitis Suppurativa
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- CHU de Reims
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- cytokine quantification (IL-10) by ELISA
研究概览
简要总结
The objective is to investigate ex vivo the inflammatory response in hidradenitis suppurativa (HS) (activation of an inflammasome, role of pro-inflammatory cytokines) in the skin of patients treated surgically for this disease.
The investigators hypothesize that Th17-derived cytokines, especially Interleukin (IL) IL-17, could serve as a relay in the inflammatory process leading to HS severity and recurrences.
详细描述
The objective is to investigate ex vivo the inflammatory response in hidradenitis suppurativa (activation of an inflammasome, role of pro-inflammatory cytokines) in the skin of patients treated surgically for this disease.
The investigators hypothesize that Th17-derived cytokines, especially IL-17, could serve as a relay in the inflammatory process leading to HS severity and recurrences.To fulfil this proposal, the investigators will aim at demonstrating and characterizing the presence of an inflammasome associated to HS disease - Hypothesis It is widely accepted that hyperkeratinisation and follicular occlusion originate infection thereof causing skin inflammation. The investigators here hypothesized that host-derived danger signals led to the release of inflammatory mediators such as IL-1β by activating an inflammasome structure.
The inflammasome is a molecular platform controlling the expression and the activation of IL-1β via different sensors. The proinflammatory cytokine IL-1β could subsequently lead to the recruitment and orientation of lymphocytes towards a Th17 subtype creating a feedback loop maintaining excessive tissue inflammation in HS.
If such a complex inflammatory process is present in HS, blocking both the bacterial-induced (IL-1 β) and the sterile-associated (IL-17) inflammation would largely improve the therapeutic benefit for HS patients.
- Experimental approach
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients with moderate to severe HS in the Dermatology department of Reims CHU, and eligible for surgery
- •Patients accepting to participate to the study (signed consent)
- •Patients affiliated to a certain social scheme
- •Controls with plastic surgery but without HS, affiliated to a certain social scheme and accepting to participate
排除标准
- •Patients <18yo
结局指标
主要结局
cytokine quantification (IL-10) by ELISA
时间窗: up to 4 days
cytokines quantification (CXCL10) by ELISA
时间窗: up to 4 days
cytokines quantification (TNFα) by ELISA
时间窗: up to 4 days
cytokine quantification (IL1-β) by ELISA
时间窗: up to 4 days
cytokines quantification (IL-13) by ELISA
时间窗: up to 4 days
cytokines quantification (IL-18) by ELISA
时间窗: up to 4 days
cytokines quantification (TGFβ) by ELISA
时间窗: up to 4 days
次要结局
未报告次要终点
